Cargando…

Prevention of large-vessel stenoses in atypical hemolytic uremic syndrome associated with complement dysregulation

Detalles Bibliográficos
Autores principales:	Davin, Jean-Claude, Majoie, Charles, Groothoff, Jaap, Gracchi, Valentina, Bouts, Antonia, Goodship, Timothy H. J., Loirat, Chantal
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Letter to the Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991236/ https://www.ncbi.nlm.nih.gov/pubmed/20652819 http://dx.doi.org/10.1007/s00467-010-1608-9

Ejemplares similares

Long-term renal function under plasma exchange in atypical hemolytic uremic syndrome
por: Davin, Jean-Claude, et al.
Publicado: (2011)

Complement and the atypical hemolytic uremic syndrome in children
por: Loirat, Chantal, et al.
Publicado: (2008)

Prophylactic plasma exchange in CD46-associated atypical haemolytic uremic syndrome
por: Davin, Jean-Claude, et al.
Publicado: (2009)

Atypical hemolytic uremic syndrome
por: Loirat, Chantal, et al.
Publicado: (2011)

CD46-associated atypical hemolytic uremic syndrome with uncommon course caused by cblC deficiency
por: Bouts, Antonia H., et al.
Publicado: (2010)

Atypical Hemolytic Uremic Syndrome
por: Kavanagh, David, et al.
Publicado: (2013)

Complement factor H and the hemolytic uremic syndrome
por: Atkinson, John P., et al.
Publicado: (2007)

Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome
por: Westra, Dineke, et al.
Publicado: (2016)

Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics
por: Geerdink, Lianne M., et al.
Publicado: (2012)

Dysregulation of Immune Cell Subpopulations in Atypical Hemolytic Uremic Syndrome
por: Chen, I-Ru, et al.
Publicado: (2023)

Complements Spurned: Our Experience with Atypical Hemolytic Uremic Syndrome
por: Nagar, Vidya S., et al.
Publicado: (2017)

Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic Syndrome
por: Zipfel, Peter F, et al.
Publicado: (2007)

Evaluation of complement regulatory components in patients with atypical hemolytic uremic syndrome
por: Soudabeh, Hosseini, et al.
Publicado: (2014)

Atypical hemolytic-uremic syndrome due to complement factor I mutation
por: Almalki, Abdullah H, et al.
Publicado: (2017)

Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies
por: Licht, Christoph, et al.
Publicado: (2015)

Postoperative Atypical Hemolytic Uremic Syndrome Associated with Complement C3 Mutation
por: Matsukuma, Eiji, et al.
Publicado: (2014)

Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome
por: Lemaire, Mathieu, et al.
Publicado: (2013)

Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation
por: Davin, Jean Claude, et al.
Publicado: (2008)

Pathogenesis of Atypical Hemolytic Uremic Syndrome
por: Yoshida, Yoko, et al.
Publicado: (2019)

The genetics of atypical hemolytic uremic syndrome
por: Feitz, Wouter J. C., et al.
Publicado: (2018)

Efficacy of Eculizumab in Coexisting Complement C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome
por: Busutti, Marco, et al.
Publicado: (2020)

Atypical Hemolytic Uremic Syndrome Caused by a Rare Complement Factor B Mutation
por: Bandaru, Sai Samyuktha
Publicado: (2022)

Complement-Amplifying Conditions in Atypical Hemolytic Uremic Syndrome: A Canadian Case Series
por: Patriquin, Christopher J., et al.
Publicado: (2022)

Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study
por: Brocklebank, Vicky, et al.
Publicado: (2023)

How atypical can Atypical Hemolytic Uremic Syndrome be?
por: Sajan, Thomas, et al.
Publicado: (2014)

Hemolytic Uremic Syndrome: Toxins, Vessels, and Inflammation
por: Cheung, Victoria, et al.
Publicado: (2014)

ATYPICAL HEMOLYTIC UREMIC SYNDROME AND GENETIC ABERRATIONS IN THE COMPLEMENT FACTOR H RELATED 5 GENE
por: Westra, Dineke, et al.
Publicado: (2012)

The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome
por: Martínez-Barricarte, Rubén, et al.
Publicado: (2015)

Thrombotic Microangiopathy with Complement Factor H Gene Mutations Unassociated with Atypical Hemolytic Uremic Syndrome
por: Oymak, Yeşim, et al.
Publicado: (2015)

Impact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndrome
por: El Karoui, Khalil, et al.
Publicado: (2019)

Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab
por: Ellithi, Moataz, et al.
Publicado: (2021)

Pregnancy-Associated Atypical Hemolytic-Uremic Syndrome
por: Saad, Antonio F., et al.
Publicado: (2016)

Pediatric Atypical Hemolytic Uremic Syndrome Advances
por: Raina, Rupesh, et al.
Publicado: (2021)

Association among Complement Factor H Autoantibodies, Deletions of CFHR, and the Risk of Atypical Hemolytic Uremic Syndrome
por: Jiang, Hong, et al.
Publicado: (2016)

C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome: Two Important Manifestations of Complement System Dysfunction
por: Bajwa, Ravneet, et al.
Publicado: (2018)

Hyperfunctional complement C3 promotes C5-dependent atypical hemolytic uremic syndrome in mice
por: Smith-Jackson, Kate, et al.
Publicado: (2019)

Complement activation in atypical hemolytic uremic syndrome and scleroderma renal crisis: a critical analysis of pathophysiology
por: Zuckerman, Roman, et al.
Publicado: (2018)

Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19
por: Leone, Valentina Fanny, et al.
Publicado: (2022)

Assesment, Treatment and Prevention of Atypical Hemolytic Uremic Syndrome
por: Nickavar, Azar, et al.
Publicado: (2013)

Critical appraisal of eculizumab for atypical hemolytic uremic syndrome
por: Palma, Lilian M Pereira, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_40hana1mqqjva6i37ht9ju01jb